EUCTR2011-002052-14-IT进行中（未招募）不适用
EURO-HIT-HLH European cooperative pilot study for testing Hybrid ImmunoTherapy for Hemophagocytic LymphoHistiocytosis - EURO-HIT-HLH
AZIENDA OSPEDALIERA MEYER0 个研究点目标入组 50 人开始时间: 2012年1月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis: The diagnosis of hemophagocytic lymphohistiocytosis must be met according to the HLH-2004 criteria. Age: Patients <18 years of age. Disease Status: The patient must have active disease at the time of enrollment. If the diagnosis is made by genetic criteria, the patient must also meet at least 4 out of 8 clinical criteria. Clinical and/or laboratory observations establishing the diagnosis of active HLH (except NK function) must occur no more than 1 week prior to study entry.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 50
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Recent treatment, within 3 months, with another therapeutic regimen for HLH. -Known active malignancy -Known rheumatologic diagnosis which may be the underlying cause of HLH, such as systemic onset juvenile idiopathic arthritis or systemic lupus erythematosus - Pregnancy (as determined by serum or urine test) or active breast feeding - Failure to provide signed informed consent
研究者
相似试验
进行中（未招募）
1 期
European cooperative study for testingTherapy for Hemophagocytic LymphoHistiocytosisHemophagocytic lymphohistiocytosisMedDRA version: 15.0Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2011-002052-14-DEAZIENDA OSPEDALIERA MEYER60
进行中（未招募）
不适用
European cooperative study for testingTherapy for Hemophagocytic LymphoHistiocytosisMedDRA version: 16.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersHemophagocytic lymphohistiocytosisEUCTR2011-002052-14-ATAZIENDA OSPEDALIERA MEYER60
进行中（未招募）
1 期
EuroHYP-1: European phase III clinical trial at multiple trial sites and with random allocation of patients to treatment groups. The trial compares whole body cooling plus best medical treatment to best medical treatment alone in patients with acute stroke.Acute ischaemic strokeMedDRA version: 18.1Level: PTClassification code 10061256Term: Ischaemic strokeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-002944-25-ITIVERSITY HOSPITAL ERLANGE98
进行中（未招募）
1 期
EuroHYP-1: European phase III clinical trial at multiple trial sites and with random allocation of patients to treatment groups. The trial compares whole body cooling plus best medical treatment to best medical treatment alone in patients with acute stroke.Acute ischaemic strokeMedDRA version: 17.0 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disordersEUCTR2012-002944-25-ESniversitätsklinikum Erlangen1,500
进行中（未招募）
1 期
EuroHYP-1: European phase III clinical trial at multiple trial sites and with random allocation of patients to treatment groups. The trial compares whole body cooling plus best medical treatment to best medical treatment alone in patients with acute stroke.EUCTR2012-002944-25-IESt James's Hospital, Dublin800